Difficulty: Medium
Average Score: 90%
Practice
Treatment with selegilin postpones the need for levodopa for 3-9 months and may retard the progression of ParkinsonÔÇ▓s disease.
Correct answer
A
Rationale
The correct answer is A) TRUE. Selegiline is a monoamine oxidase type B (MAO-B) inhibitor that is used as an adjunctive treatment in Parkinson's disease. It works by increasing dopamine levels in the brain, thereby improving motor symptoms. Studies have shown that treatment with selegiline can delay the need for levodopa therapy by 3-9 months. Additionally, selegiline has been suggested to have neuroprotective properties, potentially slowing the progression of Parkinson's disease.
Option B) FALSE is incorrect because the statement in the question is true based on clinical evidence and research findings.
Option C) None is incorrect as there is a definitive statement in the question that can be evaluated for its accuracy.
Option D) All of the above is incorrect as only option A is the correct response based on the provided information.
In an educational context, understanding the mechanism of action and the role of different medications in the treatment of Parkinson's disease is crucial for healthcare professionals. Knowing the specific effects of medications like selegiline on symptom management and disease progression can help in making informed decisions for patient care. This knowledge ensures optimal treatment outcomes and quality of life for individuals with Parkinson's disease.
Option B) FALSE is incorrect because the statement in the question is true based on clinical evidence and research findings.
Option C) None is incorrect as there is a definitive statement in the question that can be evaluated for its accuracy.
Option D) All of the above is incorrect as only option A is the correct response based on the provided information.
In an educational context, understanding the mechanism of action and the role of different medications in the treatment of Parkinson's disease is crucial for healthcare professionals. Knowing the specific effects of medications like selegiline on symptom management and disease progression can help in making informed decisions for patient care. This knowledge ensures optimal treatment outcomes and quality of life for individuals with Parkinson's disease.